» Articles » PMID: 37973721

TET1 Participates in Complete Freund's Adjuvant-induced Trigeminal Inflammatory Pain by Regulating Kv7.2 in a Mouse Model

Overview
Journal Neurosci Bull
Specialty Neurology
Date 2023 Nov 16
PMID 37973721
Authors
Affiliations
Soon will be listed here.
Abstract

Trigeminal inflammatory pain is one of the most severe pain-related disorders in humans; however, the underlying mechanisms remain largely unknown. In this study, we investigated the possible contribution of interaction between ten-eleven translocation methylcytosine dioxygenase 1 (TET1) and the voltage-gated K channel Kv7.2 (encoded by Kcnq2) to orofacial inflammatory pain in mice. We found that complete Freund's adjuvant (CFA) injection reduced the expression of Kcnq2/Kv7.2 in the trigeminal ganglion (TG) and induced orofacial inflammatory pain. The involvement of Kv7.2 in CFA-induced orofacial pain was further confirmed by Kv7.2 knockdown or overexpression. Moreover, TET1 knockdown in Tet1 mice significantly reduced the expression of Kv7.2 and M currents in the TG and led to pain-like behaviors. Conversely, TET1 overexpression by lentivirus rescued the CFA-induced decreases of Kcnq2 and M currents and alleviated mechanical allodynia. Our data suggest that TET1 is implicated in CFA-induced trigeminal inflammatory pain by positively regulating Kv7.2 in TG neurons.

Citing Articles

TET1 participates in oxaliplatin-induced neuropathic pain by regulating microRNA-30b/Nav1.6.

Zhao S, Zhang J, Zhang M, Yang Q, Li Z, Ren X J Biol Chem. 2025; 301(3):108228.

PMID: 39864621 PMC: 11894311. DOI: 10.1016/j.jbc.2025.108228.


Advances in the pathological mechanisms and clinical treatments of chronic visceral pain.

Li Y, Zhang F, Xu T, Weng R, Zhang H, Chen Q Mol Pain. 2024; 20:17448069241305942.

PMID: 39673493 PMC: 11645724. DOI: 10.1177/17448069241305942.


Post-Traumatic Trigeminal Neuropathy: Neurobiology and Pathophysiology.

Eliav T, Benoliel R, Korczeniewska O Biology (Basel). 2024; 13(3).

PMID: 38534437 PMC: 10967710. DOI: 10.3390/biology13030167.

References
1.
Abd-Elsayed A, Jackson M, Gu S, Fiala K, Gu J . Neuropathic pain and Kv7 voltage-gated potassium channels: The potential role of Kv7 activators in the treatment of neuropathic pain. Mol Pain. 2019; 15:1744806919864256. PMC: 6659175. DOI: 10.1177/1744806919864256. View

2.
Djouhri L, Malki M, Zeidan A, Nagi K, Smith T . Activation of K7 channels with the anticonvulsant retigabine alleviates neuropathic pain behaviour in the streptozotocin rat model of diabetic neuropathy. J Drug Target. 2019; 27(10):1118-1126. DOI: 10.1080/1061186X.2019.1608552. View

3.
Neubert J, Mannes A, Keller J, Wexel M, Iadarola M, Caudle R . Peripheral targeting of the trigeminal ganglion via the infraorbital foramen as a therapeutic strategy. Brain Res Brain Res Protoc. 2005; 15(3):119-26. DOI: 10.1016/j.brainresprot.2005.05.003. View

4.
Rose K, Ooi L, Dalle C, Robertson B, Wood I, Gamper N . Transcriptional repression of the M channel subunit Kv7.2 in chronic nerve injury. Pain. 2011; 152(4):742-754. PMC: 3071978. DOI: 10.1016/j.pain.2010.12.028. View

5.
Hsieh M, Ho Y, Lai C, Chou D, Wang H, Chen G . Melatonin impedes Tet1-dependent mGluR5 promoter demethylation to relieve pain. J Pineal Res. 2017; 63(4). DOI: 10.1111/jpi.12436. View